Pancreas transplant outcome with or without biological anti-T-cell therapy for induction immunosuppression with use of cyclosporine

Transplant Proc. 1994 Oct;26(5):2752-5.

Authors

D E Sutherland¹, K C Moudry-Munns, A Gruessner

Affiliation

¹ Department of Surgery, University of Minnesota, Minneapolis.

PMID: 7940866

No abstract available

Publication types

Comparative Study
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.

MeSH terms

Antilymphocyte Serum / therapeutic use*
Cyclosporine / therapeutic use*
Follow-Up Studies
Graft Survival / immunology
Humans
Immunosuppression Therapy / methods*
Kidney Transplantation / immunology
Pancreas Transplantation / immunology*
Probability
Registries
Retrospective Studies
T-Lymphocytes / immunology*
Time Factors
Treatment Outcome

Substances

Antilymphocyte Serum
Cyclosporine